...
首页> 外文期刊>Current medicinal chemistry >A(2A) Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update
【24h】

A(2A) Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update

机译:A(2A)腺苷受体激动剂及其潜在的治疗应用。 更新

获取原文
获取原文并翻译 | 示例

摘要

Background: Adenosine is an endogenous purine nucleoside, which mediates a variety of important biological processes and diseases, such as vasodilation, inflammation, cancer, wound healing, ischemia reperfusion injury, Parkinson disease, infectious diseases, and other CNS disorders. Particularly important are the A2A receptors that have been expressed in the lung, liver, heart, cardiovascular tissues, leukocytes, neutrophils, and endothelial cells. This review provides an update of the latest A2A receptor agonists developed in the period 2005-2017, their selectivity regarding other adenosine receptors and their potential therapeutic applications.
机译:背景:腺苷是一种内源性嘌呤核苷,其介导各种重要的生物过程和疾病,如血管舒张,炎症,癌症,伤口愈合,缺血再灌注损伤,帕金森病,传染病和其他CNS疾病。 特别重要的是已在肺,肝,心脏,心血管组织,白细胞,中性粒细胞和内皮细胞中表达的A2A受体。 该综述提供了最新的A2A受体激动剂在2005 - 2017年期间开发的最新A2A受体激动剂,它们对其他腺苷受体及其潜在治疗应用的选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号